{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:50:41Z","timestamp":1791219041729,"version":"4.1.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1097\/mol.0b013e3282ffaf96","type":"journal-article","created":{"date-parts":[[2008,5,6]],"date-time":"2008-05-06T03:05:13Z","timestamp":1210043113000},"page":"257-262","source":"Crossref","is-referenced-by-count":144,"title":["Dietary phospholipids, hepatic lipid metabolism and cardiovascular disease"],"prefix":"10.1097","volume":"19","author":[{"given":"Jeffrey S","family":"Cohn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Wat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin","family":"Kamili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Tandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210205","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1440-1746.2007.04824.x","article-title":"Nonalcoholic fatty liver disease: further expression of the metabolic syndrome","volume":"22","author":"Tarantino","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"R2-7-20210205","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/hep.20973","article-title":"Nonalcoholic fatty liver disease: from steatosis to cirrhosis","volume":"43","author":"Farrell","year":"2006","journal-title":"Hepatology"},{"key":"R3-7-20210205","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.2337\/dc07-0349","article-title":"Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients","volume":"30","author":"Targher","year":"2007","journal-title":"Diabetes Care"},{"key":"R4-7-20210205","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S0022-2275(20)38050-0","article-title":"Intestinal absorption of polyenephosphatidylcholine in man","volume":"23","author":"Zierenberg","year":"1982","journal-title":"J Lipid Res"},{"key":"R5-7-20210205","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1194\/jlr.M500357-JLR200","article-title":"Absorption and lipoprotein transport of sphingomyelin","volume":"47","author":"Nilsson","year":"2006","journal-title":"J Lipid Res"},{"key":"R6-7-20210205","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1194\/jlr.M500038-JLR200","article-title":"Biogenesis and speciation of nascent apoA-I-containing particles in various cell lines","volume":"46","author":"Krimbou","year":"2005","journal-title":"J Lipid Res"},{"key":"R7-7-20210205","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0022-2275(20)38453-4","article-title":"Intracellular apoA-I and apoB distribution in rat intestine is altered by lipid feeding","volume":"29","author":"Magun","year":"1988","journal-title":"J Lipid Res"},{"key":"R8-7-20210205","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s11745-001-0773-x","article-title":"Regulation of intestinal apolipoprotein A-I synthesis by dietary phosphatidylcholine in newborn swine","volume":"36","author":"Wang","year":"2001","journal-title":"Lipids"},{"key":"R9-7-20210205","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.alcohol.2004.07.008","article-title":"Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis","volume":"34","author":"Lieber","year":"2004","journal-title":"Alcohol"},{"key":"R10-7-20210205","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11894-004-0027-0","article-title":"New concepts of the pathogenesis of alcoholic liver disease lead to novel treatments","volume":"6","author":"Lieber","year":"2004","journal-title":"Curr Gastroenterol Rep"},{"key":"R11-7-20210205","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1093\/jn\/127.9.1800","article-title":"Polyenylphosphatidylcholine attenuates alcohol-induced fatty liver and hyperlipidemia in rats","volume":"127","author":"Navder","year":"1997","journal-title":"J Nutr"},{"key":"R12-7-20210205","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1093\/jn\/113.12.2403","article-title":"The contrasting effect of dietary phosphatidylethanolamine and phosphatidylcholine on serum lipoproteins and liver lipids in rats","volume":"113","author":"Imaizumi","year":"1983","journal-title":"J Nutr"},{"key":"R13-7-20210205","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3177\/jnsv.38.471","article-title":"The effect of dietary safflower phospholipid and soybean phospholipid on plasma and liver lipids in rats fed a hypercholesterolemic diet","volume":"38","author":"Iwata","year":"1992","journal-title":"J Nutr Sci Vitaminol"},{"key":"R14-7-20210205","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3177\/jnsv.41.635","article-title":"Effect of dietary soybean phospholipids and fats differing in the degree of unsaturation on fatty acid synthesis and oxidation in rat liver","volume":"41","author":"Kabir","year":"1995","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"key":"R15-7-20210205","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1079\/BJN19960148","article-title":"Cholesterol-lowering effect of soyabean lecithin in normolipidaemic rats by stimulation of biliary lipid secretion","volume":"75","author":"Polichetti","year":"1996","journal-title":"Br J Nutr"},{"key":"R16-7-20210205","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/ps\/76.5.689","article-title":"Dietary safflower phospholipid reduces liver lipids in laying hens","volume":"76","author":"An","year":"1997","journal-title":"Poult Sci"},{"key":"R17-7-20210205","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/S0024-3205(00)00840-7","article-title":"Dietary polyenylphosphatidylcholine decreases cholesterolemia in hypercholesterolemic rabbits: role of the hepato-biliary axis","volume":"67","author":"Polichetti","year":"2000","journal-title":"Life Sci"},{"key":"R18-7-20210205","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0955-2863(02)00253-X","article-title":"Effects of dietary soybean lecithin on plasma lipid transport and hepatic cholesterol metabolism in rats","volume":"14","author":"LeBlanc","year":"2003","journal-title":"J Nutr Biochem"},{"key":"R19-7-20210205","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.nut.2004.11.019","article-title":"Dietary phosphatidylcholine alleviates fatty liver induced by orotic acid","volume":"21","author":"Buang","year":"2005","journal-title":"Nutrition"},{"key":"R20-7-20210205","doi-asserted-by":"crossref","first-page":"7170","DOI":"10.1021\/jf071225x","article-title":"Effect of dietary omega 3 phosphatidylcholine on obesity-related disorders in obese Otsuka Long-Evans Tokushima fatty rats","volume":"55","author":"Shirouchi","year":"2007","journal-title":"J Agric Food Chem"},{"key":"R21-7-20210205","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1093\/jn\/131.9.2358","article-title":"Egg phosphatidylcholine decreases the lymphatic absorption of cholesterol in rats","volume":"131","author":"Jiang","year":"2001","journal-title":"J Nutr"},{"key":"R22-7-20210205","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1093\/jn\/133.11.3571","article-title":"Egg sphingomyelin lowers the lymphatic absorption of cholesterol and alpha-tocopherol in rats","volume":"133","author":"Noh","year":"2003","journal-title":"J Nutr"},{"key":"R23-7-20210205","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/ajcn\/84.2.312","article-title":"Dietary sphingolipids lower plasma cholesterol and triacylglycerol and prevent liver steatosis in APOE*3Leiden mice","volume":"84","author":"Duivenvoorden","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"R24-7-20210205","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1203\/pdr.0b013e31802d7780","article-title":"Dietary lecithin protects against cholestatic liver disease in cholic acid-fed Abcb4-deficient mice","volume":"61","author":"Lamireau","year":"2007","journal-title":"Pediatr Res"},{"key":"R25-7-20210205","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cmet.2006.03.007","article-title":"The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis","volume":"3","author":"Li","year":"2007","journal-title":"Cell Metab"},{"key":"R26-7-20210205","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/BF02535661","article-title":"Influence of dietary soybean and egg lecithins on lipid responses in cholesterol-fed guinea pigs","volume":"23","author":"O'Brien","year":"1988","journal-title":"Lipids"},{"key":"R27-7-20210205","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0021-9150(98)00132-4","article-title":"Soy lecithin reduces plasma lipoprotein cholesterol and early atherogenesis in hypercholesterolemic monkeys and hamsters: beyond linoleate","volume":"140","author":"Wilson","year":"1998","journal-title":"Atherosclerosis"},{"key":"R28-7-20210205","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1161\/01.CIR.0000089375.60050.35","article-title":"Oral synthetic phospholipid (DMPC) raises high-density lipoprotein cholesterol levels, improves high-density lipoprotein function, and markedly reduces atherosclerosis in apolipoprotein E-null mice","volume":"108","author":"Navab","year":"2003","journal-title":"Circulation"},{"key":"R29-7-20210205","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/ajcn\/49.2.266","article-title":"Lecithin intake and serum cholesterol","volume":"49","author":"Knuiman","year":"1989","journal-title":"Am J Clin Nutr"},{"key":"R30-7-20210205","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/BF00879871","article-title":"\u201cEssential\u201d phospholipids versus nicotinic acid in the treatment of patients with type IIb hyperlipoproteinemia and ischemic heart disease","volume":"9","author":"Klimov","year":"1995","journal-title":"Cardiovasc Drugs Ther"},{"key":"R31-7-20210205","first-page":"420","article-title":"Evaluation of the effects of Neptune Krill Oil on the clinical course of hyperlipidemia","volume":"9","author":"Bunea","year":"2004","journal-title":"Altern Med Rev"},{"key":"R32-7-20210205","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1194\/jlr.M400438-JLR200","article-title":"Phosphatidylinositol increases HDL-C levels in humans","volume":"46","author":"Burgess","year":"2005","journal-title":"J Lipid Res"},{"key":"R33-7-20210205","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/MOL.0b013e3281574570","article-title":"Lipid metabolism and metabolic disease: defining new targets","volume":"18","author":"Cohn","year":"2007","journal-title":"Curr Opin Lipidol"}],"container-title":["Current Opinion in Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MOL.0b013e3282ffaf96","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:57:57Z","timestamp":1786035477000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00041433-200806000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/mol.0b013e3282ffaf96","relation":{},"ISSN":["0957-9672"],"issn-type":[{"value":"0957-9672","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}